derived from tumor-associated antigen and mage family antigen, nucleic acid sequence, coding for them, their uses in vaccine preparation, process for vaccine and vaccine production.

摘要

The present invention relates to novel proteins and to their production, from the MAGE family. In particular, to a MAGE protein fused to an immunological fusion partner, such as Lipoprotein D. Such antigens maybe formulated to provide vaccines for the treatment of a range of tumours. Novel methods for purifying MAGE proteins are also provided. IMAGE